NEWS, EVENTS, and DEADLINES

March 18, 2026

Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events


 
 
 

Rutgers Roadmaps AI Week 2026

 
 
 

Joy at Work

Mini Grant Program


Ideas to foster well-being

in the workplace.

 

252 Nassau St 2nd Fl, Princeton

How Wearables and AI Are Reshaping Preventive Care


Ricky Bloomfield Oura


Mar 20, 12 pm

Suicide Risk in Pre-Adolescent Children and Digital Interventions


David Pagliaccio

Columbia University


April 3, 2026

 




The Night Science Workshop


Faculty-focused, centering on the creative process underlying research and effective mentoring of PhD students and postdoctoral scholars.

March 24, 12 - 1:30

 
 


Find out what impact your research or innovation could have in solving real-world problems

Rutgers-Newark - In-person
April 17, 10 am - 2 pm

Rutgers: Busch Campus

In-person, May 5, 12 - 4 pm


Transform your technology into benefits for society

Hosted by Princeton -Virtual


May 5, 13, and 26

Clinical Trials Day 2026

Advancing Health Through Research

Join us in celebrating the vital role of clinical research professionals and shining a light on the next generation of the translational science workforce

 

 
 

Funding Available

Integrated Population Health Data Project



The iPHD aims to improve the health, safety, security, and well-being of New Jersey residents, as well as the efficiency of state government, by securely linking administrative datasets to support approved research projects.


Limited funding will be available to support up to two (2) full or partial waivers (up to $25,000) of data fees in each 2026 Cycle of the iPHD Project. 

 

NJ ACTS in the NEWS

Rutgers Health Researchers over $2M in Funding from the National Institute of Environmental Health Sciences (NIEHS)

Zorimar Rivera-Núñez, an assistant professor with the Rutgers School of Public Health, will help lead a collaborative, multi-institutional project to examine how exposure to zearalenone – a mycoestrogen produced by mold with estrogen-like activity – may affect pregnancy outcomes and children’s growth.


The effort – coheaded by Emily Barrett, George G. Rhoads Endowed Legacy Professor and vice chair of the Department of Biostatistics and Epidemiology at the school – is backed by over $2 million in funding from the National Institute of Environmental Health Sciences (NIEHS).

Dr. Rivera-Núñez is an NJ ACTS 2025 Pilot Grant recipient. Dr. Barrett is the NJ ACTS Lead for Element E, Advancing Translational Science by Addressing Roadblocks.

 

CTSA News and Events

NCATS, NIH, and Federal News and Events

Cycle XVI of CTSA Working Group Proposals is now open!


The CTSA Steering Committee is looking for Working Group proposals that align within the following key areas:

  • Translational science methods and best practices
  • Artificial intelligence
  • Clinical and health research innovation
  • Solution-oriented approaches in health disparities research
  • National training curricula in CTS



Submission Period March 1 - March 31



Email SteeringCmte@ccos.ctsa.io with any questions

 

Strategies to Engage Providers & Recruit Patients


April 15

12 - 1


Register

Introducing REDCap+: Transformative Technical Innovations


May 4

12 - 1


Register

NJ ACTS Publications

NJ ACTS Publication Highlights


Persistent transgene expression in peripheral tissues one year post intravenous and intramuscular administration of AAV vectors containing the alphaherpesvirus latency-associated promoter 2. Maturana CJ, Engel EA. Frontiers in Virology (Lausanne, Switzerland), 28 Mar 2024, 4:1379991 https://doi.org/10.3389/fviro.2024.1379991 PMID: 38665693 


Barriers to pre-exposure prophylaxis use among women: a systematic literature review. Alene Mathurin, Barbara Tafuto, Doreen Lechner. Principles and Practice of Clinical Research. (2024) 10(1). https://doi.org/10.21801/

 

ICYMI

Rutgers Innovation Showcase - March 19th, 1:30 - 6:30 pm. Register

Yale Medical AI Symposium - March 26th. For More Info, to Register or Submit a Poster Proposal

Wildfires and Their Impacts on the Environment and Health - May 6th, 9 am - 5 pm. Flyer and Register

 

NJ ACTS is a partnership between Rutgers, NJIT, Princeton, and RWJ Barnabas Health. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.

Training Components

Element B

Administration

Element C1

Workforce Development

Element C2

Community & Stakeholder Engagement

Element D1

*Biostatistics, Epidemiology &

Research Design (BERD)

*Team Science

*Regulatory Knowledge & Support

*Special Populations in Research

*Biomarkers

*Genetically informed Research

Education & Training (GREAT)

*Clinical Trials Office

Element D2

Clinical & Translational Science Pilots

Element D3

Clinical Informatics

Element E1

Clinical & Translational Science Research: Novel Genetic Services Model

Element E2

Clinical & Translational Science Research: Translating Evidence on Opioid Overdose


Additional Components

*Mentored Career Development DEVELOP (K12)

*Predoctoral Training ASCENT (T32)

*Short-Term Research CREST (R25)



Working Groups

*Health Policy in Action

*Dissemination & Implementation Science

*Team Science

*Learning Health System

*Engagement for Impact

CTSA Hub Funding Opportunities

Become a members of NJ ACTS

How to cite the CTSA Grant

 
Connect with us
Facebook  Twitter  Youtube  LinkedIn

This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.

 

New Jersey Alliance for Clinical and Translational Science

89 French St., Suite 4211

New Brunswick, NJ

 

Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved

Send story ideas to NJACTS@rbhs.rutgers.edu

 

UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019 (pre-5/1/2024), K12TR004788(starting 7/1/2024), T32TR004782 (starting 9/1/2024), R25TR004777 (starting 9/1/2024)